Shionogi Renews 10-Year Goal After Infectious Disease Success

Push For Faster Xocova Growth

 
• By Lisa Takagi

Shionogi renews its 10-year strategic plan originally announced in 2020 following the successful debut of COVID-19 therapeutic Xocova. Fulfilling its 2025 goals ahead of schedule, its new strategy focuses on HIV and COVID-19 and new product launches.

Shionogi moved its timing to leap earlier than expected before the pandemic.
Shionogi makes early transition to new growth plan • Source: Shutterstock

More from Business

More from Scrip